Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anatomic variables contributing to a higher periprocedural incidence of stroke and TIA in carotid artery stenting: single center experience of 833 consecutive cases.
Werner M, Bausback Y, Bräunlich S, Ulrich M, Piorkowski M, Friedenberger J, Schuster J, Botsios S, Scheinert D, Schmidt A. Werner M, et al. Among authors: friedenberger j. Catheter Cardiovasc Interv. 2012 Aug 1;80(2):321-8. doi: 10.1002/ccd.23483. Epub 2012 Mar 15. Catheter Cardiovasc Interv. 2012. PMID: 22422560
Renal denervation for hypertension refractory to renal artery stenting.
Bausback Y, Friedenberger J, Hertting K, Werner M, Branzan D, Freitas B, Piorkowski M, Schmidt A, Scheinert D. Bausback Y, et al. Among authors: friedenberger j. J Endovasc Ther. 2014 Apr;21(2):181-90. doi: 10.1583/13-4566R.1. J Endovasc Ther. 2014. PMID: 24754276
Intracoronary versus intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: 6-month effects on infarct size and left ventricular function. The randomised Leipzig Immediate PercutaneouS Coronary Intervention Abciximab i.v. versus i.c. in ST-Elevation Myocardial Infarction Trial (LIPSIAbciximab-STEMI).
Eitel I, Friedenberger J, Fuernau G, Dumjahn A, Desch S, Schuler G, Thiele H. Eitel I, et al. Among authors: friedenberger j. Clin Res Cardiol. 2011 May;100(5):425-32. doi: 10.1007/s00392-010-0260-5. Epub 2010 Dec 2. Clin Res Cardiol. 2011. PMID: 21125288 Clinical Trial.
Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.
Thiele H, Schindler K, Friedenberger J, Eitel I, Fürnau G, Grebe E, Erbs S, Linke A, Möbius-Winkler S, Kivelitz D, Schuler G. Thiele H, et al. Among authors: friedenberger j. Circulation. 2008 Jul 1;118(1):49-57. doi: 10.1161/CIRCULATIONAHA.107.747642. Epub 2008 Jun 16. Circulation. 2008. PMID: 18559698 Clinical Trial.